These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3398356)
1. The dexamethasone suppression test for Japanese with eating disorders. Fukata S; Tamai H; Takaichi Y; Mori K; Matsubayashi S; Nakagawa T Jpn J Psychiatry Neurol; 1988 Mar; 42(1):59-64. PubMed ID: 3398356 [TBL] [Abstract][Full Text] [Related]
2. The dexamethasone suppression test in bulimia nervosa. O'Brien G; Hassanyeh F; Leake A; Schapira K; White M; Ferrier IN Br J Psychiatry; 1988 May; 152():654-6. PubMed ID: 3167440 [TBL] [Abstract][Full Text] [Related]
3. Dexamethasone suppression test and plasma dexamethasone levels in bulimia. Walsh BT; Lo ES; Cooper T; Lindy DC; Roose SP; Gladis M; Glassman AH Arch Gen Psychiatry; 1987 Sep; 44(9):797-800. PubMed ID: 3632253 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa. Neudeck P; Jacoby GE; Florin I Physiol Behav; 2001 Jan; 72(1-2):93-8. PubMed ID: 11239985 [TBL] [Abstract][Full Text] [Related]
5. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Monteleone P; Di Lieto A; Tortorella A; Longobardi N; Maj M Psychiatry Res; 2000 May; 94(2):121-9. PubMed ID: 10808037 [TBL] [Abstract][Full Text] [Related]
6. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms. Bruce KR; Steiger H; Israël M; Groleau P; Ng Ying Kin NM; Ouellette AS; Sycz L; Badawi G Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):241-6. PubMed ID: 22575215 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Monteleone P; Luisi M; Colurcio B; Casarosa E; Monteleone P; Ioime R; Genazzani AR; Maj M Psychosom Med; 2001; 63(1):62-8. PubMed ID: 11211066 [TBL] [Abstract][Full Text] [Related]
10. Enhanced cortisol suppression in eating disorders with impulsive personality features. Díaz-Marsá M; Carrasco JL; Basurte E; Sáiz J; López-Ibor JJ; Hollander E Psychiatry Res; 2008 Feb; 158(1):93-7. PubMed ID: 18182170 [TBL] [Abstract][Full Text] [Related]
11. Alpha-1-acid glycoprotein in major depressive and eating disorders. Healy D; Calvin J; Whitehouse AM; White W; Wilton-Cox H; Theodorou AE; Lawrence KM; Horton RW; Paykel ES J Affect Disord; 1991; 22(1-2):13-20. PubMed ID: 1652602 [TBL] [Abstract][Full Text] [Related]
12. [Clinical application of the dexamethasone suppression test in the differentiation of subgroups in anorexia nervosa]. Hidalgo Rodrigo MI; Díaz González RJ; Cabranes Díaz JA; Hidalgo Rodrigo MA; Santiago Guervós M Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(2):115-21. PubMed ID: 1651047 [TBL] [Abstract][Full Text] [Related]
13. The dexamethasone suppression test in anorexia nervosa. The influence of weight, depression, adrenocorticotrophic hormone and dexamethasone. Schweitzer I; Szmukler GI; Maguire KP; Harrison LC; Tuckwell V; Davies BM Br J Psychiatry; 1990 Nov; 157():713-7. PubMed ID: 2177677 [TBL] [Abstract][Full Text] [Related]
14. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease. Ferron F; Considine RV; Peino R; Lado IG; Dieguez C; Casanueva FF Clin Endocrinol (Oxf); 1997 Mar; 46(3):289-93. PubMed ID: 9156037 [TBL] [Abstract][Full Text] [Related]
16. Changes in melatonin levels but not cortisol levels are associated with depression in patients with eating disorders. Kennedy SH; Garfinkel PE; Parienti V; Costa D; Brown GM Arch Gen Psychiatry; 1989 Jan; 46(1):73-8. PubMed ID: 2910222 [TBL] [Abstract][Full Text] [Related]